Insider Trading Summary for Neurocrine Biosciences Inc. (NBIX): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
30-May-24 4:38 PM View:	29-May-24 Planned Option Sale ($5.34M)	Sherwin Stephen A Director		Neurocrine Biosciences Inc. - NBIX	19% 22.3K to 26.5K	0	0	--	--	Show Txns Hide Txns

21-May-24 5:27 PM View:	17-May-24 Planned Option Sale ($297.86K)	Pops Richard F Director		Neurocrine Biosciences Inc. - NBIX	7% 29.51K to 31.61K	0	0	--	--	Show Txns Hide Txns

15-Aug-24 5:21 PM View:	13-Aug-24 Planned Option Sale ($1.74M)	Lyons Gary A Director		Neurocrine Biosciences Inc. - NBIX	(71%) 412.39K to 119.05K	0	0	--	--	Show Txns Hide Txns

04-Jan-24 6:26 PM View:	02-Jan-24 Planned Option Sale ($1.45M)	Rastetter William H Director		Neurocrine Biosciences Inc. - NBIX	21% 42.78K to 51.74K	0	0	--	--	Show Txns Hide Txns

05-Aug-24 5:18 PM View:	01-Aug-24 Planned Private Option Sale ($461.42K)	Lippoldt Darin Chief Legal Officer		Neurocrine Biosciences Inc. - NBIX	(15%) 46.8K to 39.74K	0	0	--	--	Show Txns Hide Txns

17-Apr-24 5:19 PM View:	15-Apr-24 Planned Private Option Sale ($2.64M)	Benevich Eric Chief Commercial Officer		Neurocrine Biosciences Inc. - NBIX	5% 38.81K to 40.78K	0	0	--	--	Show Txns Hide Txns

21-May-24 5:15 PM View:	17-May-24 Option Exercise 0	Morrow George J Director		Neurocrine Biosciences Inc. - NBIX	100% 0 to 4.2K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:40 PM View:	13-Feb-24 Private Sale (Planned) ($179.67K)	Gano Kyle Chief Business Development Off		Neurocrine Biosciences Inc. - NBIX	4% 130.25K to 135.17K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:43 PM View:	13-Feb-24 Private Sale (Planned) ($376.70K)	Gorman Kevin Charles Chief Executive Officer Director		Neurocrine Biosciences Inc. - NBIX	3% 499.75K to 514.6K	0	0	--	--	Show Txns Hide Txns

15-Aug-24 5:12 PM View:	13-Aug-24 Planned Private Option Sale ($2.12M)	Abernethy Matt Chief Financial Officer		Neurocrine Biosciences Inc. - NBIX	7% 29.57K to 31.53K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:51 PM View:	13-Feb-24 Private Sale (Planned) ($148.12K)	Roberts Eiry Chief Medical Officer		Neurocrine Biosciences Inc. - NBIX	(20%) 29.52K to 23.72K	0	0	--	--	Show Txns Hide Txns

05-Aug-24 5:40 PM View:	01-Aug-24 Planned Option Sale ($1.94M)	Cooke Julie Chief Human Resources Officer		Neurocrine Biosciences Inc. - NBIX	5% 17.26K to 18.2K	0	0	--	--	Show Txns Hide Txns

21-May-24 5:06 PM View:	17-May-24 Planned Option Sale ($156.85K)	Norwalk Leslie V Director		Neurocrine Biosciences Inc. - NBIX	100% 0 to 0.99K	0	0	--	--	Show Txns Hide Txns

21-May-24 5:35 PM View:	17-May-24 Planned Option Sale ($156.94K)	Sharp Shalini Director		Neurocrine Biosciences Inc. - NBIX	100% 0 to 0.99K	0	0	--	--	Show Txns Hide Txns

21-May-24 4:46 PM View:	17-May-24 Option Exercise 0	Mercier Johanna Director		Neurocrine Biosciences Inc. - NBIX	100% 0 to 2.1K	0	0	--	--	Show Txns Hide Txns

15-Feb-24 5:48 PM View:	13-Feb-24 Private Sale (Planned) ($190.37K)	Onyia Jude Chief Scientific Officer		Neurocrine Biosciences Inc. - NBIX	(7%) 14.06K to 13.13K	0	0	--	--	Show Txns Hide Txns

07-Oct-24 10:00 PM View:	03-Oct-24 Private Sale (Planned) ($147.19K)	Boyer David W. Chief Corp. Affairs Officer		Neurocrine Biosciences Inc. - NBIX	(95%) 6.99K to 0.38K	0	0	--	--	Show Txns Hide Txns

15-Aug-24 5:06 PM View:	13-Aug-24 Sale (Planned) ($615.42K)	Delaet Ingrid Chief Regulatory Officer		Neurocrine Biosciences Inc. - NBIX	(63%) 6.73K to 2.51K	0	0	--	--	Show Txns Hide Txns

Neurocrine Biosciences Inc. (NBIX)

Last Year

25-Nov-23 -- 24-Nov-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--